+39 06 5782665
contact@donawa.com
Italy - UK - USA

COMPANY NEWS

Maria Donawa to speak at the 9th EAAR Annual Conference on 24-25 February 2025

The 9th EAAR Annual Conference on New Medical Device Regulations (RMD 2025) will take place in Brussels, Belgium, on 24-25 February 2025, featuring speakers from across the MedTech industry, including regulators and notified bodies. Organized by the European Association of Authorised Representatives (EAAR), the conference serves as an inclusive platform for all stakeholders across the…

Clinical Data Requirements: EU vs. US – Critical Differences and Strategies

On 25 September 2024, Donawa Lifescience President Dr. Maria E. Donawa spoke at the webinar titled ‘Clinical Data Requirements: EU vs. US – Critical Differences and Strategies’. Dr. Donawa was joined as a speaker by Tom Melvin, Associate Professor of Medical Device Regulatory Affairs, Trinity College, Dublin. The webinar was hosted by MedTech Leading Voice…

Maria Donawa posts a second article on device clinical evaluation plans on LinkedIn

Donawa Lifescience President, Maria E. Donawa, M.D., has authored a second ‘Regulatory Recap’ article on LinkedIn covering interpretational difficulties with requirements for Clinical Evaluation Plans (CEPs) under the EU Medical Device Regulation (MDR, 2017/745) titled: ‘CEPs: What Does “State of the Art” Modify?’ The topic arises because of confusion among manufacturers, notified bodies, and competent…

Global News

Commission launches public consultation on MDR/IVDR

The European Commission has launched a public consultation seeking stakeholder input on the effectiveness of the EU Medical Devices Regulation (MDR, 2017/745) and the In Vitro Diagnostic Medical Devices Regulation (IVDR, 2017/746) in a targeted evaluation. An announcement stated that the evaluation will help the Commission “take stock” and assess the effectiveness, efficiency, and proportionality…

MedTech Europe post-EPSCO meeting statement on MDR/IVDR reforms

Following the EPSCO meeting on 3 December 2024 at which the subject of MDR/IVDR reform was discussed, MedTech Europe has published its response to the out come of the meeting, available from here. In the statement, the industry association comments: “[W]e call for the swift adoption of immediate measures, and before the targeted evaluation’s conclusions….

MedTech Europe issues position paper on the mandatory use of EUDAMED

In the light of the anticipated go-live of most of the European database on medical devices (EUDAMED) modules in 2025, MedTech Europe has summarised in a position paper its viewpoint on ensuring a smooth transition to its mandatory use, in which it calls for improved accessibility, efficiency and consistency through technical and regulatory measures in…